Last reviewed · How we verify
A Study of RD14-01 in Patients With Advanced Solid Tumors
This study will evaluate the safety and tolerability of RD14-01, a ROR1-targeted CAR T-cell therapy, in patients with ROR1+ advanced solid tumors.
Details
| Lead sponsor | Shen Lin |
|---|---|
| Phase | EARLY_PHASE1 |
| Status | UNKNOWN |
| Enrolment | 24 |
| Start date | Thu Dec 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Sun Dec 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Solid Tumor
Interventions
- RD14-01 Cell injection